This page follows insider dealings at Optomed Oyj as filed with Nasdaq Helsinki, a company from the Health Care sector. Between 23 October 2025 and 23 October 2026, 14 insiders published 48 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
No insider has bought Optomed Oyj shares on the open market in the past twelve months. Filings reach the Nasdaq Helsinki feed a median of 1 day after the trade. The regulation allows three business days to notify a trade (MAR article 19).
Across the 125 companies tracked on its exchange, the median is 15 filings; at 48 filings, this issuer sits above that mark. Over the whole record (from 2019), the tally stands at no purchases and 1 sale.
For comparison within the same sector, see the insider buying recorded at EssilorLuxottica and Dynavox Group AB. Source: insider filings from Nasdaq Helsinki. Past trades are no guide to future returns.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 186 declarations
Optomed Oyj is a Finnish company focused on developing diagnostic solutions for eye diseases. It is listed on the Helsinki Stock Exchange.
Purchases our model currently ranks for the recommendations list.
All recommendations